Latest MR-proADM News

November 2019

publicationMR-proADM in Suspected Infection

MR-proADM test for use with clinical deterioration scores in cases of suspected infection

NICE has developed a medtech innovation briefing (MIB) on the MR-proADM test for use with clinical deterioration scores in cases of suspected infection. The main points from the evidence summarised in this briefing are from 5 observational studies of 3,217 people with suspected infections in hospital. They show that MR-proADM can improve accuracy of infection diagnosis and can predict the infection's severity.

Read the full publication here >

 

May 2019

press-releaseSepsis / Emergency Department (ED)

New Study Results Find That The Blood Biomarker MR-proADM May Prevent Early Hospital Discharge in Patients with Developing Sepsis

Multi-centre analysis shows that incorporation of MR-proADM (mid-regional proadrenomedullin) into an early management of patients with suspected infection protocol may aid rapid clinical decision making in the emergency department

Read press release here >

 

News Archive

thermo scientific applied biosystems invitrogen fisher scientific unity lab service